Impact of COVID‐19 on Renal Transplant Recipients in a National Transplant Center

Documenti analoghi

• sFGL2 as a Potential Immunosuppressive Biomarker Associated With COVID‐19 Severity in Kidney Transplant Recipients
  di: Yufei Zhang, et al.
  Pubblicazione: (2025)
• Prevalence of latent tuberculosis infection in Asian nations: A systematic review and meta‐analysis
  di: Abhigan B. Shrestha, et al.
  Pubblicazione: (2024)
• Biomarker role of maternal soluble human leukocyte antigen G in pre‐eclampsia: A meta‐analysis
  di: Abhinav Bhattarai, et al.
  Pubblicazione: (2024)
• Impact of COVID‐19 on Respiratory Virus Infections in Children, Japan, 2018–2023
  di: Emi Takashita, et al.
  Pubblicazione: (2025)
• Safety and 1‐Year Outcomes After Transplanting Hearts From SARS‐CoV‐2 Positive Donors: Insights From an International Analysis
  di: Sabina P. W. Guenther, et al.
  Pubblicazione: (2025)